These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 171964)

  • 1. Effect of 25(OH)vitamin D3 on urinary excretion of cyclic adenosine monophosphate.
    Popovtzer MM; Robinette JB
    Am J Physiol; 1975 Oct; 229(4):907-10. PubMed ID: 171964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for interference of 25 (OH) vitamin D3 with phosphaturic action of calcitonin.
    Popovtzer MM; Blum MS; Flis RS
    Am J Physiol; 1977 May; 232(5):E515-21. PubMed ID: 193407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine does not interfere with the antiphosphaturic effect of 25(OH) vitamin D3 in the rat.
    Friedlaender MM; Wald H; Kopolovic J; Popovtzer MM
    Miner Electrolyte Metab; 1988; 14(2-3):103-9. PubMed ID: 2837627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal effect of vitamin D metabolites: evidence for the essential role of the 25(OH) group.
    Friedlaender MM; Kornberg Z; Wald H; Popovtzer MM
    Am J Physiol; 1983 Jun; 244(6):F674-8. PubMed ID: 6602555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 25-Hydroxycholecalciferol and 1,25-dihydroxycholecalciferol enhances phosphaturia in rats with reduced renal mass: evidence for a PTH-dependent mechanism.
    Rubinger D; Wald H; Popovtzer MM
    Miner Electrolyte Metab; 1990; 16(6):348-54. PubMed ID: 1965220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for interference of 25(OH)vitamin D3 with phosphaturic action of glucagon.
    Popovtzer MM; Wald H
    Am J Physiol; 1981 Apr; 240(4):F269-75. PubMed ID: 7223886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vivo and in vitro effect of calmodulin antagonists on the renal actions of 25(OH) vitamin D3 in the rat.
    Friedlaender MM; Darmon D; Wald H; Popovtzer MM
    Pflugers Arch; 1989 Dec; 415(3):372-80. PubMed ID: 2560171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3.
    Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H
    J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the renal tubular effects of vitamin D by cycloheximide in the rat.
    Brezis M; Wald H; Shilo R; Popovtzer MM
    Pflugers Arch; 1983 Aug; 398(3):247-52. PubMed ID: 6688870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphosphaturic action of 25 (OH) vitamin D3 in experimental Fanconi syndrome.
    Popovtzer MM; Mehandru SK; Saghafi D; Blum MS
    Am J Physiol; 1979 Feb; 236(2):E90-7. PubMed ID: 217276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary cyclic adenosine 3',5'-monophosphate response in McCune-Albright syndrome: clinical evidence for altered renal adenylate cyclase activity.
    Zung A; Chalew SA; Schwindinger WF; Levine MA; Phillip M; Jara A; Counts DR; Kowarski AA
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3576-81. PubMed ID: 8530601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of resistance to the phosphaturic effect of the parathyroid hormone in the hamster.
    Knox FG; Preiss J; Kim JK; Dousa TP
    J Clin Invest; 1977 Apr; 59(4):675-83. PubMed ID: 14974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute effect of 25-hydroxycholecalciferol on renal handling of phosphorus. Evidence for a parathyroid hormone-dependent mechanism.
    Popovtzer MM; Robinette JB; DeLuca HF; Holick MF
    J Clin Invest; 1974 Mar; 53(3):913-21. PubMed ID: 4812447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone does not increase nephrogenous cyclic AMP excretion by the dog.
    Fox J; Heath H
    Endocrinology; 1980 Dec; 107(6):2124-5. PubMed ID: 6253291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal adenylate cyclase and the interrelationship between parathyroid hormone and vitamin D in the regulation of urinary phosphate and adenosine cyclic 3',5'-monophosphate excretion.
    Forte LR; Nickols GA; Anast CS
    J Clin Invest; 1976 Mar; 57(3):559-68. PubMed ID: 175088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Has vitamin D a direct renal effect on the tubular reabsorption of phosphate? A study in parathyroidectomized (PTX) and non-PTX man.
    Madsen S; Olgaard K
    Adv Exp Med Biol; 1978; 103():111-23. PubMed ID: 717102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoaciduria of vitamin D deficiency is independent of PTH levels and urinary cyclic AMP.
    Dabbagh S; Chesney R; Gusowski N; Mathews MC; Padilla M; Theissen M; Slatopolsky E
    Miner Electrolyte Metab; 1989; 15(4):221-32. PubMed ID: 2548072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal handling of phosphate during extracellular volume expansion and parathyroid hormone administration.
    Rubinger D; Popovtzer MM
    Miner Electrolyte Metab; 1987; 13(5):323-32. PubMed ID: 3670228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D reduces renal NaPi-2 in PTH-infused rats: complexity of vitamin D action on renal P(i) handling.
    Friedlaender MM; Wald H; Dranitzki-Elhalel M; Zajicek HK; Levi M; Popovtzer MM
    Am J Physiol Renal Physiol; 2001 Sep; 281(3):F428-33. PubMed ID: 11502592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evidence for the intermediary role of 3',5'-cyclic AMP in parathyroid hormone-induced stimulation of 1alpha,25-dihydroxyvitamin D3 synthesis in rats.
    Horiuchi N; Suda T; Takahashi H; Shimazawa E; Ogata E
    Endocrinology; 1977 Sep; 101(3):969-74. PubMed ID: 196836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.